US biotech Akari Therapeutics (Nasdaq: AKTX), which is developing novel payload antibody drug conjugates (ADCs), today ...

Shares in US drug major Eli Lilly were a hefty 8% down early Thursday after the Indianapolis firm announced its first quarter financial results and latest guidance for 2025.